tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

IDEXX Laboratories Inc

IDXX
Add to Watchlist
539.590USD
-5.410-0.99%
Close 07-23 16:00（ET）Quotes delayed by 15 min
42.76BMarket Cap
39.43P/E TTM

IDEXX Laboratories Inc

539.590
-5.410-0.99%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

IDXX Financials

See IDEXX Laboratories Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

IDEXX Laboratories Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
--/3.95
Revenue / Forecast
--/1.20B
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
4.30B
10.42%
EPS(YoY)
13.17
22.35%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
17.15%3.50
17.63%3.11
21.19%3.43
48.60%3.66
5.26%2.98
12.81%2.64
10.77%2.83
-8.84%2.46
9.92%2.84
12.74%2.34
--2.55
--2.70
--2.58
--2.08
----
----
----
----
----
----
Revenue
14.26%1.14B
14.28%1.09B
13.29%1.11B
10.55%1.11B
3.56%998.43M
5.84%954.29M
6.56%975.54M
6.35%1.00B
7.10%964.10M
8.81%901.60M
8.78%915.53M
9.65%943.63M
7.61%900.20M
3.43%828.57M
3.85%841.66M
4.16%860.55M
7.57%836.55M
11.12%801.09M
12.28%810.42M
29.57%826.14M
Net Profit
14.74%278.45M
14.82%248.19M
17.94%274.61M
44.61%293.99M
3.01%242.68M
11.12%216.15M
9.71%232.84M
-9.34%203.30M
10.06%235.58M
12.96%194.52M
17.29%212.23M
69.90%224.24M
10.36%214.05M
5.80%172.21M
3.25%180.94M
-34.85%131.98M
-5.04%193.97M
-6.88%162.77M
19.84%175.24M
36.02%202.58M
Net Margin
0.42%24.41%
0.47%22.76%
4.10%24.85%
30.81%26.50%
-0.53%24.31%
4.98%22.65%
2.96%23.87%
-14.75%20.26%
2.76%24.44%
3.81%21.58%
--23.18%
--23.76%
--23.78%
--20.78%
----
----
----
----
----
----
Gross Margin
1.47%63.35%
0.91%60.35%
1.20%61.83%
1.50%62.62%
1.50%62.44%
2.47%59.80%
2.08%61.10%
1.63%61.70%
1.99%61.52%
-0.28%58.36%
--59.85%
--60.71%
--60.32%
--58.53%
----
----
----
----
----
----
Debt to assets ratio
-1.07%28.94%
-3.95%25.30%
10.93%28.93%
19.77%33.14%
3.74%29.26%
-9.40%26.34%
-20.99%26.08%
-23.32%27.67%
-34.15%28.20%
-40.77%29.08%
--33.01%
--36.08%
--42.83%
--49.09%
----
----
----
----
----
----
Income Statement
Revenue
14.26%1.14B
14.28%1.09B
13.29%1.11B
10.55%1.11B
3.56%998.43M
5.84%954.29M
6.56%975.54M
6.35%1.00B
7.10%964.10M
8.81%901.60M
8.78%915.53M
9.65%943.63M
7.61%900.20M
3.43%828.57M
3.85%841.66M
4.16%860.55M
7.57%836.55M
11.12%801.09M
12.28%810.42M
29.57%826.14M
Operating profit
14.55%362.59M
20.60%315.61M
16.77%354.85M
41.41%373.05M
5.88%316.53M
6.68%261.69M
10.39%303.89M
-10.92%263.80M
6.62%298.96M
8.29%245.30M
12.44%275.28M
65.38%296.14M
12.91%280.40M
13.72%226.53M
8.35%244.83M
-30.93%179.07M
0.29%248.34M
7.62%199.19M
31.48%225.96M
34.16%259.25M
Net Profit
14.74%278.45M
14.82%248.19M
17.94%274.61M
44.61%293.99M
3.01%242.68M
11.12%216.15M
9.71%232.84M
-9.34%203.30M
10.06%235.58M
12.96%194.52M
17.29%212.23M
69.90%224.24M
10.36%214.05M
5.80%172.21M
3.25%180.94M
-34.85%131.98M
-5.04%193.97M
-6.88%162.77M
19.84%175.24M
36.02%202.58M
Balance Sheet
Current assets
10.36%1.45B
1.00%1.41B
3.02%1.48B
-10.88%1.36B
-12.27%1.32B
-6.38%1.40B
3.58%1.43B
29.65%1.53B
30.67%1.50B
35.75%1.50B
30.73%1.38B
13.06%1.18B
5.48%1.15B
15.26%1.10B
12.88%1.06B
4.15%1.04B
-0.73%1.09B
-10.08%955.65M
7.98%938.04M
28.43%1.00B
Total current liabilities
14.40%1.30B
7.58%1.15B
24.04%1.25B
9.60%1.22B
18.74%1.14B
12.23%1.07B
4.02%1.01B
26.34%1.12B
-10.20%956.90M
-23.00%951.55M
-18.47%970.19M
-24.23%883.86M
9.71%1.07B
61.84%1.24B
87.73%1.19B
78.97%1.17B
56.50%971.34M
31.03%763.58M
20.31%633.85M
20.57%651.81M
Total assets
5.35%3.39B
1.74%3.35B
1.07%3.39B
-2.46%3.33B
-4.17%3.21B
1.03%3.29B
8.57%3.35B
18.95%3.41B
19.41%3.35B
18.68%3.26B
16.91%3.09B
10.11%2.87B
8.32%2.81B
12.70%2.75B
10.66%2.64B
8.09%2.61B
11.40%2.59B
6.22%2.44B
16.53%2.39B
23.02%2.41B
Total liabilities
3.61%1.83B
2.78%1.75B
5.36%1.83B
2.04%1.87B
-1.06%1.77B
-4.35%1.70B
-3.15%1.73B
3.25%1.83B
-9.29%1.78B
-16.96%1.78B
-17.33%1.79B
-17.36%1.78B
0.74%1.97B
22.37%2.14B
32.74%2.16B
29.22%2.15B
20.26%1.95B
5.14%1.75B
1.49%1.63B
-1.39%1.66B
Total equity
7.46%1.56B
0.63%1.61B
-3.51%1.56B
-7.68%1.46B
-7.71%1.45B
7.46%1.60B
24.71%1.62B
44.47%1.58B
86.53%1.57B
143.87%1.48B
172.57%1.30B
139.35%1.09B
31.46%841.10M
-11.78%608.74M
-36.99%476.00M
-38.92%457.01M
-9.05%639.80M
9.04%689.99M
71.26%755.46M
173.67%748.22M
Cash Flow Statement
Net operating income
11.89%266.25M
35.77%355.76M
82.82%402.34M
-25.20%185.74M
19.83%237.96M
4.87%262.02M
-19.22%220.08M
23.96%248.31M
7.98%198.59M
44.07%249.85M
44.14%272.43M
204.20%200.31M
60.33%183.91M
-17.40%173.43M
0.96%189.00M
-71.85%65.85M
-7.81%114.71M
-4.10%209.96M
-3.06%187.21M
12.40%233.96M
Net investment
-13.29%-33.54M
29.40%-28.13M
-63.95%-44.87M
-2.19%-33.63M
72.31%-29.61M
-30.91%-39.84M
1.69%-27.37M
-19.79%-32.91M
-170.67%-106.94M
38.18%-30.43M
43.42%-27.84M
50.13%-27.47M
5.56%-39.51M
-11.78%-49.23M
0.97%-49.20M
68.46%-55.09M
-70.16%-41.84M
-180.69%-44.04M
-155.28%-49.68M
-611.28%-174.66M
Net financing
35.99%-211.43M
-52.80%-355.70M
-7.67%-313.31M
21.22%-165.63M
-129.27%-330.32M
-128.57%-232.78M
-576.10%-290.98M
-39.20%-210.24M
1.37%-144.07M
12.75%-101.84M
71.08%-43.04M
-64.33%-151.03M
-983.69%-146.08M
29.61%-116.72M
32.88%-148.83M
49.00%-91.91M
89.60%-13.48M
-41763.32%-165.82M
-112.82%-221.73M
-11.57%-180.22M

FAQs

What is the total revenue of IDEXX Laboratories Inc?

According to IDEXX Laboratories Inc's FY2025 earnings report, its total revenue reached 4.30B, with a year-on-year change of 3.90B.

What are the current assets of IDEXX Laboratories Inc?

According to IDEXX Laboratories Inc's FY2025 earnings report, its current assets were 1.41B, with a year-on-year change of 1.00.

What are the total assets of IDEXX Laboratories Inc?

According to IDEXX Laboratories Inc's FY2025 earnings report, its total assets of IDEXX Laboratories Inc were 3.35B, with a year-on-year change of 1.74.

What are the total liabilities of IDEXX Laboratories Inc?

According to IDEXX Laboratories Inc's FY2025 earnings report, its total liabilities of IDEXX Laboratories Inc were 1.75B, with a year-on-year change of 2.78.

What is the total equity of IDEXX Laboratories Inc?

According to IDEXX Laboratories Inc's FY2025 earnings report, its total equity of IDEXX Laboratories Inc was 1.61B, with a year-on-year change of 0.63.

What is the net operating income of IDEXX Laboratories Inc?

According to IDEXX Laboratories Inc's FY2025 earnings report, its net operating income of IDEXX Laboratories Inc was 1.36B, with a year-on-year change of 20.43.

What is the net investment of IDEXX Laboratories Inc?

According to IDEXX Laboratories Inc's FY2025 earnings report, its net investment of IDEXX Laboratories Inc was -136.24M, with a year-on-year change of 34.20.

What is the net financing of IDEXX Laboratories Inc?

According to IDEXX Laboratories Inc's FY2025 earnings report, its net financing of IDEXX Laboratories Inc was -1.16B, with a year-on-year change of -32.67.

What is the Earnings Per Share (EPS) of IDEXX Laboratories Inc?

According to IDEXX Laboratories Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 13.17, with a year-on-year change of 22.35.

What is the net income of IDEXX Laboratories Inc?

According to IDEXX Laboratories Inc's FY2025 earnings report, its net income was 1.06B, with a year-on-year change of 19.33.

What is the net margin of IDEXX Laboratories Inc?

According to IDEXX Laboratories Inc's FY2025 earnings report, its net profit margin was 24.62, with a year-on-year change of 8.06.

What is the gross margin of IDEXX Laboratories Inc?

According to IDEXX Laboratories Inc's FY2025 earnings report, its gross margin was 61.80, with a year-on-year change of 1.25.

What is the debt-to-asset ratio of IDEXX Laboratories Inc?

According to IDEXX Laboratories Inc's FY2025 earnings report, its debt-to-asset ratio was 25.30, with a year-on-year change of -3.95.

What is the Return on Equity (ROE) of IDEXX Laboratories Inc?

According to IDEXX Laboratories Inc's FY2025 earnings report, its Return on Equity (ROE) was 66.20, with a year-on-year change of 14.82.

What is the Return on Assets (ROA) of IDEXX Laboratories Inc?

According to IDEXX Laboratories Inc's FY2025 earnings report, its Return on Assets (ROA) was 31.89, with a year-on-year change of 17.70.

What is the operating profit of IDEXX Laboratories Inc?

According to IDEXX Laboratories Inc's FY2025 earnings report, its operating profit was 1.36B, with a year-on-year change of 20.43.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy